DK1838670T3 - Fremgangsmåde til fremstilling af carvedilol og dets enantiomere - Google Patents
Fremgangsmåde til fremstilling af carvedilol og dets enantiomereInfo
- Publication number
- DK1838670T3 DK1838670T3 DK05815876.7T DK05815876T DK1838670T3 DK 1838670 T3 DK1838670 T3 DK 1838670T3 DK 05815876 T DK05815876 T DK 05815876T DK 1838670 T3 DK1838670 T3 DK 1838670T3
- Authority
- DK
- Denmark
- Prior art keywords
- enantiomers
- carvedilol
- preparation
- relates
- mixtures
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/82—Carbazoles; Hydrogenated carbazoles
- C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Indole Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04106438 | 2004-12-09 | ||
| PCT/EP2005/056469 WO2006061364A1 (en) | 2004-12-09 | 2005-12-05 | Process for the preparation of carvedilol and its enantiomers |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1838670T3 true DK1838670T3 (da) | 2010-03-01 |
Family
ID=35985349
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK05815876.7T DK1838670T3 (da) | 2004-12-09 | 2005-12-05 | Fremgangsmåde til fremstilling af carvedilol og dets enantiomere |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US20090005429A1 (da) |
| EP (1) | EP1838670B1 (da) |
| JP (1) | JP2008523025A (da) |
| CN (1) | CN100591668C (da) |
| AT (1) | ATE445601T1 (da) |
| CA (1) | CA2589699A1 (da) |
| CY (1) | CY1110688T1 (da) |
| DE (1) | DE602005017194D1 (da) |
| DK (1) | DK1838670T3 (da) |
| ES (1) | ES2333537T3 (da) |
| HR (1) | HRP20100023T1 (da) |
| IL (1) | IL183449A0 (da) |
| PL (1) | PL1838670T3 (da) |
| PT (1) | PT1838670E (da) |
| SI (1) | SI1838670T1 (da) |
| WO (1) | WO2006061364A1 (da) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL153688A0 (en) | 2000-06-28 | 2003-07-06 | Teva Pharma | Carvedilol |
| CN1298322C (zh) | 2002-01-15 | 2007-02-07 | 特瓦制药工业有限公司 | 卡维地洛的结晶固体及其制备方法 |
| KR100746455B1 (ko) * | 2006-02-23 | 2007-08-03 | 안국약품 주식회사 | 고광학순도의 키랄 카베딜롤의 제조방법 |
| US8022094B2 (en) | 2006-06-28 | 2011-09-20 | Teva Pharmaceutical Industries Ltd. | Carvedilol phosphate |
| CN102190613B (zh) * | 2010-03-14 | 2014-06-25 | 浙江华海药业股份有限公司 | 一种卡维地洛的制备方法 |
| SG10201501936PA (en) | 2010-03-23 | 2015-05-28 | Siga Technologies Inc | Polymorphic forms st-246 and methods of preparation |
| WO2015031914A1 (en) * | 2013-08-30 | 2015-03-05 | Uti Limited Partnership | Store overload-induced calcium release inhibitors and methods for producing and using the same |
| CN104592096A (zh) * | 2014-12-24 | 2015-05-06 | 江苏苏南药业实业有限公司 | 一种s-卡维地洛的制备方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2815926A1 (de) * | 1978-04-13 | 1979-10-18 | Boehringer Mannheim Gmbh | Neue carbazolyl-(4)-oxy-propanolamin-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
| DE3319027A1 (de) * | 1983-05-26 | 1984-11-29 | Boehringer Mannheim Gmbh, 6800 Mannheim | Verfahren zur herstellung von optisch aktiven carbazol-derivaten, neue r- und s-carbazol-derivate, sowie arzneimittel, die diese verbindungen enthalten |
| EP0893440A1 (en) * | 1997-07-22 | 1999-01-27 | Roche Diagnostics GmbH | Thermodynamically stable modification of 1-(4-carbazolyloxy)-3-[2-(2-methoxyphenoxy)ethylamino]-2-propanole, process for its preparation and pharmaceutical compositions containing it |
| IL153688A0 (en) * | 2000-06-28 | 2003-07-06 | Teva Pharma | Carvedilol |
-
2005
- 2005-12-05 DK DK05815876.7T patent/DK1838670T3/da active
- 2005-12-05 PT PT05815876T patent/PT1838670E/pt unknown
- 2005-12-05 PL PL05815876T patent/PL1838670T3/pl unknown
- 2005-12-05 EP EP05815876A patent/EP1838670B1/en active Active
- 2005-12-05 ES ES05815876T patent/ES2333537T3/es active Active
- 2005-12-05 WO PCT/EP2005/056469 patent/WO2006061364A1/en active Application Filing
- 2005-12-05 SI SI200530863T patent/SI1838670T1/sl unknown
- 2005-12-05 US US11/720,110 patent/US20090005429A1/en not_active Abandoned
- 2005-12-05 CA CA002589699A patent/CA2589699A1/en not_active Abandoned
- 2005-12-05 CN CN200580042214A patent/CN100591668C/zh not_active Expired - Fee Related
- 2005-12-05 AT AT05815876T patent/ATE445601T1/de active
- 2005-12-05 DE DE602005017194T patent/DE602005017194D1/de active Active
- 2005-12-05 JP JP2007544890A patent/JP2008523025A/ja active Pending
-
2007
- 2007-05-28 IL IL183449A patent/IL183449A0/en unknown
-
2009
- 2009-12-08 CY CY20091101281T patent/CY1110688T1/el unknown
-
2010
- 2010-01-13 HR HR20100023T patent/HRP20100023T1/hr unknown
-
2011
- 2011-10-27 US US13/282,868 patent/US20120041044A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JP2008523025A (ja) | 2008-07-03 |
| HRP20100023T1 (hr) | 2010-02-28 |
| WO2006061364A1 (en) | 2006-06-15 |
| PT1838670E (pt) | 2009-12-18 |
| US20120041044A1 (en) | 2012-02-16 |
| SI1838670T1 (sl) | 2010-04-30 |
| DE602005017194D1 (de) | 2009-11-26 |
| PL1838670T3 (pl) | 2010-03-31 |
| ATE445601T1 (de) | 2009-10-15 |
| CN101072753A (zh) | 2007-11-14 |
| IL183449A0 (en) | 2007-09-20 |
| EP1838670A1 (en) | 2007-10-03 |
| EP1838670B1 (en) | 2009-10-14 |
| CA2589699A1 (en) | 2006-06-15 |
| CN100591668C (zh) | 2010-02-24 |
| ES2333537T3 (es) | 2010-02-23 |
| US20090005429A1 (en) | 2009-01-01 |
| CY1110688T1 (el) | 2015-06-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1110688T1 (el) | Διεργασια για την παρασκευη καρβεδιλολης και εναντιομερων αυτης | |
| EA200702346A1 (ru) | КРИСТАЛЛИЧЕСКАЯ ФОРМА 1-ХЛОР-4-(β-D-ГЛЮКОПИРАНОЗ-1-ИЛ)-2-[4-((S)-ТЕТРАГИДРОФУРАН-3-ИЛОКСИ)БЕНЗИЛ]БЕНЗОЛА, СПОСОБ ЕЁ ПОЛУЧЕНИЯ И ЕЁ ПРИМЕНЕНИЕ ДЛЯ ПРИГОТОВЛЕНИЯ ЛЕКАРСТВЕННЫХ СРЕДСТВ | |
| EA200600203A1 (ru) | Производные 2-(хиноксалин-5-илсульфониламино)бензамида в качестве модуляторов сск2 | |
| DE502006006854D1 (de) | Substituierte benzo (d) isoaxol-3-yl-amin-verbindungen als analgetika | |
| ATE411994T1 (de) | Herstellung eines substituierten chinoxalins von hoher reinheit | |
| NO20066078L (no) | Metode for fremstilling av Entecavir og nye mellomprodukter derav via karbon-silisium oksidasjon | |
| NO20071254L (no) | Fremgangsmate for fremstilling av irbesartan og mellomprodukter derav. | |
| NO20071012L (no) | Fremgangsmate for fremstilling av D-erytro-2,2-difluor-2-deoksy-1-oksoribosederivat | |
| DE602006010584D1 (de) | Stereoselektive synthese bestimmter trifluormethylsubstituierter alkohole | |
| NO20074047L (no) | Ny fremgangsmate for fremstilling av substituerte indoler | |
| DK1670778T3 (da) | Omlejrede pentanoler, en fremgangsmåde til fremstilling heraf og anvendelse heraf som betændelsehæmmende | |
| DE502005008057D1 (de) | Substituierte cyclopenten-verbindungen | |
| NO20081617L (no) | Metoder for fremstilling av Glutaminsyrederivater | |
| DK1928839T3 (da) | Fremgangsmåde til fremstilling af 5-fluor-1,3-dialkyl-1H-pyrazol-4-carboxylsyrefluorider | |
| DK1713801T3 (da) | Fremgangsmåde til fremstilling af 1-(2S,3S)-2-benzhydryl-N-(5-tert-butyl-2-methoxybenzyl)quinuclidin-3-amin | |
| DK2046754T3 (da) | Fremgangsmåde til fremstilling af alkylanilider ud fra halogenbenzenderivater | |
| DK1926732T3 (da) | Fremgangsmåde til fremstillingen af carbapenemforbindelser | |
| DK1720823T3 (da) | Ny fremgangsmåde til syntese af substituerede alpha-amino-indanderivater | |
| DK1831239T3 (da) | Fremgangsmåde til fremstilling af 17-hydroxy-6 beta, 7 beta, 15 beta, 16 beta-bismethylen-17alpha-pregn-4-en-3-on-21-carboxylsyre-lambda-lacton og nøgle-mellemprodukter til denne fremgangsmåde | |
| DK1527065T3 (da) | Fremgangsmåde til fremstilling af (S) - 3 methylamino-1-(thien-2-yl) propan-1-o1 | |
| DE602006015465D1 (de) | Cycloalkylidinverbindungen als selektive modulatoren des östrogenrezeptors | |
| NO20081948L (no) | Heksahydro-cykloheptapyrazol cannabinoide modulatorer | |
| ATE542796T1 (de) | N-sulfonylcarboximidamidverbindungen als apoptosepromotoren | |
| DK1817326T3 (da) | Industriel fremgangsmåde til fremstilling af 17-hydroxy-6-beta, 7-beta, 15-beta, 16-beta-bismethylen-3-oxo-17-alpha-pregn-4-en-21-carboxylsyre-gamma-lacton og nøglemellemprodukter for denne fremgangsmåde | |
| EA200700550A1 (ru) | Производные алкилидентетрагидронафталина, способ их получения и их применение в качестве противовоспалительных средств |